|
|
|
Insider
Information: |
Lew Jennifer |
Relationship: |
|
City: |
Berkeley |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
219,545 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$5,484,562 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
219,545 |
|
|
Total
Value |
$5,484,562 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Dynavax Technologies Corp |
DVAX |
VP, Finance & PAO |
2012-09-14 |
2,332 |
|
0 |
Premium* |
|
Chinook Therapeutics Inc |
KDNY |
Chief Financial Officer |
2019-05-01 |
135,155 |
2015-04-20 |
0 |
Premium* |
|
Annexon, Inc. |
ANNX |
|
2024-02-20 |
82,058 |
2020-07-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
56 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
KDNY |
Chinook Therapeutics Inc |
Sr. Vice President of Finance |
|
2016-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
37,300 |
43,500 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Sr. Vice President of Finance |
|
2017-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
23,300 |
65,895 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Sr. Vice President of Finance |
|
2017-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
11,650 |
73,988 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
|
2018-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
67,825 |
141,813 |
0 |
- |
|
ANNX |
Annexon, Inc. |
EVP & Chief Financial Officer |
|
2022-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
14,500 |
0 |
- |
|
ANNX |
Annexon, Inc. |
EVP & Chief Financial Officer |
|
2022-07-11 |
4 |
A |
$0.00 |
$0 |
D/D |
9,375 |
23,875 |
0 |
- |
|
ANNX |
Annexon, Inc. |
EVP & Chief Financial Officer |
|
2023-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
18,975 |
48,517 |
0 |
- |
|
ANNX |
Annexon, Inc. |
EVP & CHIEF FINANCIAL OFFICER |
|
2024-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
39,000 |
84,651 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Sr. Vice President of Finance |
|
2015-11-18 |
4 |
AS |
$28.52 |
$191,426 |
D/D |
(6,712) |
2,000 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Sr. Vice President of Finance |
|
2015-12-03 |
4 |
AS |
$29.84 |
$156,486 |
D/D |
(5,242) |
2,000 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Sr. Vice President of Finance |
|
2016-01-06 |
4 |
AS |
$25.64 |
$134,765 |
D/D |
(5,242) |
6,200 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Sr. Vice President of Finance |
|
2016-09-19 |
4 |
AS |
$14.95 |
$95,082 |
D/D |
(6,360) |
42,595 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Sr. Vice President of Finance |
|
2016-11-10 |
4 |
AS |
$14.95 |
$163,105 |
D/D |
(10,910) |
42,595 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Sr. Vice President of Finance |
|
2017-06-28 |
4 |
AS |
$11.19 |
$134,236 |
D/D |
(12,000) |
42,595 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Sr. Vice President of Finance |
|
2017-07-03 |
4 |
AS |
$11.14 |
$133,632 |
D/D |
(12,000) |
42,595 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Sr. Vice President of Finance |
|
2017-08-07 |
4 |
AS |
$12.17 |
$80,290 |
D/D |
(6,600) |
42,595 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Sr. Vice President of Finance |
|
2017-09-01 |
4 |
AS |
$11.70 |
$77,242 |
D/D |
(6,600) |
42,595 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Sr. Vice President of Finance |
|
2017-10-02 |
4 |
AS |
$10.61 |
$69,995 |
D/D |
(6,600) |
62,338 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Sr. Vice President of Finance |
|
2017-11-15 |
4 |
AS |
$8.95 |
$59,070 |
D/D |
(6,600) |
62,338 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Sr. Vice President of Finance |
|
2017-12-01 |
4 |
AS |
$9.46 |
$62,433 |
D/D |
(6,600) |
62,338 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
|
2019-04-08 |
4 |
AS |
$4.07 |
$75,775 |
D/D |
(18,601) |
135,155 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
|
2019-05-01 |
4 |
AS |
$4.20 |
$78,136 |
D/D |
(18,602) |
135,155 |
0 |
- |
|
ANNX |
Annexon, Inc. |
EVP & Chief Financial Officer |
|
2021-03-23 |
4 |
AS |
$27.51 |
$142,176 |
D/D |
(5,000) |
2,000 |
0 |
- |
|
ANNX |
Annexon, Inc. |
EVP & Chief Financial Officer |
|
2021-05-27 |
4 |
AS |
$22.24 |
$77,835 |
D/D |
(3,500) |
2,000 |
0 |
- |
|
ANNX |
Annexon, Inc. |
EVP & Chief Financial Officer |
|
2021-09-13 |
4 |
AS |
$20.01 |
$70,034 |
D/D |
(3,500) |
2,000 |
0 |
- |
|
56 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|